Many studies have demonstrated that COL5A2 is differentially expressed in various tumors, such as gastric cancer, esophageal squamous cell carcinoma, non-small cell lung cancer (lung squamous carcinoma and lung adenocarcinoma), and colorectal cancer, and is associated with poor prognosis [44–48]. Here, COL5A2 is linked to non-small cell lung carcinoma.